Personalized medicine: importance of clinical interpretative skills for real-world patient care

被引:0
|
作者
Gryn, Steven E. [1 ]
Kim, Richard B. [1 ]
机构
[1] Univ Western Ontario, Div Clin Pharmacol, Dept Med, London Hlth Sci Centre UH, London, ON N6A 5A5, Canada
基金
加拿大健康研究院;
关键词
azathioprine; clinical pharmacology; clopidogrel; metoprolol; pharmacogenetics; pharmacogenomics; statin; warfarin; IMPLEMENTATION CONSORTIUM GUIDELINES; PERCUTANEOUS CORONARY INTERVENTION; CYP2C19; GENOTYPE; BREAST-CANCER; COST-EFFECTIVENESS; ACTIVE METABOLITE; CYP2D6; CARDIOVASCULAR OUTCOMES; ANTIPLATELET THERAPY; PLATELET REACTIVITY;
D O I
10.2217/PME.14.16
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sequencing of the human genome led to great hopes and expectations for a 'genomics revolution' where disease diagnosis as well as therapies would be based on an individual's genetic makeup. Although significant progress has been made, a number of challenging hurdles must be overcome prior to the broader adoption and implementation of pharmacogenomics and personalized medicine as a part of standard patient care. One aspect of pharmacogenomics-based personalized medicine that has not garnered as much attention, a key focus of this perspective, is the importance of interpreting pharmacogenomic test results in a patient-specific clinical context, and expert physicians and other allied health care providers with the requisite expertise in clinical pharmacology and genomics who are able to provide such services.
引用
收藏
页码:395 / 408
页数:14
相关论文
共 50 条
  • [11] Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
    Blonde, Lawrence
    Khunti, Kamlesh
    Harris, Stewart B.
    Meizinger, Casey
    Skolnik, Neil S.
    ADVANCES IN THERAPY, 2018, 35 (11) : 1763 - 1774
  • [12] Pharmacogenomics, Theranostics and Personalized Medicine - the complexities of clinical trials: challenges in the developing world
    Limaye, Nimita
    APPLIED AND TRANSLATIONAL GENOMICS, 2013, 2 : 17 - 21
  • [13] Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World Investigation
    Thomas, Cameron D.
    Franchi, Francesco
    Keeley, Ellen C.
    Rossi, Joseph S.
    Winget, Marshall
    Anderson, R. David
    Dempsey, Alyssa L.
    Gong, Yan
    Gower, Megan N.
    Kerensky, Richard A.
    Kulick, Natasha
    Malave, Jean G.
    McDonough, Caitrin W.
    Mulrenin, Ian R.
    Starostik, Petr
    Beitelshees, Amber L.
    Johnson, Julie A.
    Stouffer, George A.
    Winterstein, Almut G.
    Angiolillo, Dominick J.
    Lee, Craig R.
    Cavallari, Larisa H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 146 - 155
  • [14] The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice
    Green, Jennifer B.
    Crowley, Matthew J.
    Thirunavukkarasu, Sathish
    Maruthur, Nisa M.
    Oldenburg, Brian
    DIABETES CARE, 2024, 47 (08) : 1299 - 1310
  • [15] Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
    Kashihara, Naoki
    Kohsaka, Shun
    Kanda, Eiichiro
    Okami, Suguru
    Yajima, Toshitaka
    KIDNEY INTERNATIONAL REPORTS, 2019, 4 (09): : 1248 - 1260
  • [16] The importance of renal function in anemic patients treated with edoxaban after orthopedic surgery in a real-world clinical setting: A retrospective study
    Izushi, Yasuhisa
    Takami, Yoichiro
    Ushio, Soichiro
    Tetsunaga, Tomonori
    Shiota, Naofumi
    Yamamoto, Hiroshi
    Sato, Toru
    Kitamura, Yoshihisa
    MEDICINE, 2022, 101 (47) : E31298
  • [17] Assessment of the current status of real-world pharmacogenomic testing: informed consent, patient education, and related practices
    Pereira, Lucas
    Haidar, Cyrine-Eliana
    Haga, Susanne B.
    Cisler, Anna G.
    Hall, April
    Shukla, Sanjay K.
    Hebbring, Scott J.
    Leary, Emili J. W.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [18] Incorporating real-world clinical practice in multiple sclerosis economic evaluations
    McQueen, R. Brett
    Nair, Kavita V.
    Vollmer, Timothy L.
    Campbell, Jonathan D.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 869 - 872
  • [19] Clinical impact of fractional flow reserve in a real-world cohort of patients
    Xu, Bo
    Whitbourn, Robert
    Wilson, Andrew
    Burns, Andrew T.
    Williams, Paul D.
    Judkins, Christopher
    MacIsaac, Andrew
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : 251 - 252
  • [20] Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    ENDOCRINE REVIEWS, 2021, 42 (05) : 658 - 690